Third-party NDA reviews advocated in NDMA testimony to House subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
NDMA "STRONGLY SUPPORTS" THIRD-PARTY OTC REVIEW by "accredited independent authoritative review organizations," according to the Nonprescription Drug Manufacturers Association's written testimony to the House Commerce Committee's health subcommittee. The testimony, part of a May 1-2 hearing on FDA reform legislation, generally supports the OTC-related provisions in HR 3199.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning